Centiva Capital, LP Morpho Sys Ag Transaction History
Centiva Capital, LP
- $3.72 Billion
- Q1 2024
A detailed history of Centiva Capital, LP transactions in Morpho Sys Ag stock. As of the latest transaction made, Centiva Capital, LP holds 262,000 shares of MOR stock, worth $4.87 Million. This represents 0.13% of its overall portfolio holdings.
Number of Shares
262,000Holding current value
$4.87 Million% of portfolio
0.13%Shares
0 transactions
| Quarter | Operation | Price Per share | shares change | shares Held | SEC Form |
|---|
Others Institutions Holding MOR
# of Institutions
72Shares Held
11.3MCall Options Held
320KPut Options Held
1.1M-
Glazer Capital, LLC New York, NY1.45MShares$27 Million2.74% of portfolio
-
Balyasny Asset Management LLC Chicago, IL1.3MShares$24.3 Million0.04% of portfolio
-
Ubs Group Ag1.17MShares$21.7 Million0.01% of portfolio
-
Black Rock Inc. New York, NY1.02MShares$18.9 Million0.0% of portfolio
-
Carlson Capital L P Dallas, TX950KShares$17.7 Million1.45% of portfolio
About MorphoSys AG
- Ticker MOR
- Exchange OTC
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 136,614,000
- Market Cap $2.54B
- Description
- MorphoSys AG, a commercial-stage biopharmaceutical company, engages in the discovery, development, and commercialization of therapeutic antibodies for patients suffering from cancer and autoimmune diseases in the United States. It offers Tafasitamab, an antibody for the treatment of B cell malignancies, including diffuse large B-cell lymphoma, f...